Refractec Viewpoint Hyperopia Approval Limited To Temporary Treatment

Refractec is positioning its Viewpoint CK conductive keratoplasty system as a potentially favorable alternative to LASIK for hyperopia (farsightedness) despite FDA approval limiting the product to "temporary" treatment